We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Technique Designs Nucleic Acid Probes to Detect Rapidly Mutating Bacteria and Viruses

By LabMedica International staff writers
Posted on 16 Feb 2023

The COVID-19 pandemic has shown that the microbes responsible for some infections can rapidly mutate into variants which evade detection and treatment. More...

Now, researchers have developed a technique called AutoPLP that designs nucleic acid probes to help quickly, accurately and easily detect new variants of pathogens which can be hard to trace. This could help prevent infections that have the potential to spread quickly due to these dangerous variants.

Several diagnostics like the ones based on the polymerase chain reaction (PCR) detect pathogens by analyzing genetic material. Rolling circle amplification (RCA) works similarly but eliminates the need for complex temperature cycling unlike PCR. Both the approaches need nucleic acid probes with sequences that match those of the target pathogen in specific locations, although RCA utilizes highly specific “padlock probes” (PLPs). When a pathogen mutates, there is also a change in its genetic sequence, forcing researchers to keep redesigning their probes. So, researchers from the Indian Institute of Technology (IIT) Madras (Chennai, India) set out to create a tool that could automatically design these PLPs, as well as systematically take into account all the required technical parameters simultaneously to make the overall process easier and more robust.

The new tool, a computer program termed AutoPLP has been named after the PLPs it designs. The program takes the genome sequences of similar pathogens as input and runs a series of analyses and database searches, outputting a set of customized PLP sequences. Using the program, the researchers designed probes against the rabies virus and Mycobacterium tuberculosis. In the case of the rabies virus, AutoPLP targeted three genes, yielding probes with a higher and narrower range of melting temperatures as compared to those in the literature. In the case of M. tuberculosis, the team designed 13 probes that specifically targeted the two genes responsible for drug-resistant strains with the program. According to the researchers, the new tool could speed up the discovery of new pathogen variants, thus helping fight them rapidly and effectively through the use of precise molecular diagnostics.

Related Links:
IIT Madras


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Portable POCT Blood Gas Analyzer
BD100
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.